Problems and perspectives in pharmaceutics and drug discovery


Drugs used in traumatology are analyzed in scientific studies. The process of treating patients was in-vestigated, types of diseases and associated conditions were analyzed. The nomenclature of drugs used in traumatology was studied, and groups of relatively effective and affordable drugs were identified. The re-sult of pharmacoeconomic analysis of drugs used in traumatology, the cost of treatment with a tablet num-ber 4 "Alovell" 70 mg compared with a tablet number 4 "Ostalon" 70 mg, defined savings in the amount of 44,930 for one patient and scientifically based rational use of funds .

First Page


Last Page



1. O'zbekiston Respublikasi Prezidenti Shavkat Mirziyoyevning 2017 yil 5 yanvar kuni sog'liqni saqlash sohasining bir guruh yetakchi mutaxassislari bilan "Farzandlari sog'lom yurtning kelajagi buyukdir" uchrashuvdagi ma'ruzasi // Xalq so'zi. 2017 yil 5 yanvar, 243 (6678). 2-b. 2. Doskina Ye.V., Doskin A.V. Bol i eye osobennosti pri osteoporoze. Farmateka. 2012. 3(236). S.63-66. 3. Arruebo M(1), Vilaboa N, Santamaria J. Drug delivery from internally implanted biomedical devices used in traumatology and in orthopedic surgery // Expert Opin Drug Deliv. (Spain). - 2010.-Vol.7(5). - P.589-603. 4. Brandgo CM, Ferry F, Machado GP, Guerra Jr AA, Andrade EI, Cherchiglia ML, Acurcio Fde A. Public spending on drugs for the treatment of osteoporosis in post-menopause // Rev Saude Publica (Brazil). - 2013. - Vol.47(2). - P.390-402. 5. Davey P. Pharmacoeconomics of appropriate antimicrobial use //Diagn Microbiol Infect Dis (Scotland). - 2005. - Vol.22;(1-2). - P. 225-229. 6. Hiligsmann M, Evers SM, Ben Sedrine W, Kanis JA, Ramaekers B, Reginster JY, Silverman S, Wyers CE, Boonen A. A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosis // Pharmacoeconomics (The Netherlands). - 2015. - Vol.33(3) . - P. 205-224. 7. Czler T(1), Uluzay Z(1), Snal A(1), Altentayu F(1). Comparison of switch-therapy modalities (enoxaparin to rivaroxaban /dabigatran) and enoxaparin monotherapy after hip and knee replacement // Acta Orthop Traumatol Turc. (Turky).- 2015.- Vol.49(3). - 255-259. 8. Shaman Moser S, Yu J, Goldshtein I, Ish-Shalom S, Rouach V,Shalev V, Modi A, Chodick G. Cost and Consequences of Nonadherence With Oml Bisphosphonate Therapy : Findings From a Real-World Data Analysis //Ann Pharmacother (Israel). - 2016. - VoL 50(4). -P. 262-269. 9. Tarantino U, Celt M, Feola M, Liuni FM, Resmini G. lolascon G.A new antiresorptive approach to the treatment of fragility fractures: long-term efficacy> and safety of denosumah //Aging Clin Exp Res (Italy) -2013.- Vol.25 Suppl l.—P. 65-S69. 10. Wright BA(I), Roberts CS. Seligson D. Malkani AL. McCabe SJ. Cost of antibiotic beads is justified: a study of open fracture wounds and chronic osteomyelitis //J Long Term EffMed Implants (USA). — 2007. — Vol. 17(3). —P. 181-185. 11. Самандароеа О.Д.ц. Травматологияда фманиладигам дори воситаяарининг фармакошрписодий пицяияи: Магистр академик дирижасини олишучун ёзияган диссертация. — Ташкент: ТФИ, 2017. — 96-6.